7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-03-31 2005-09-30 2005-06-30 2005-03-31 2004-09-30 
      
    		                                                                              
      net income
    		579,000,000 522,000,000 622,000,000 572,000,000 681,000,000 477,000,000 2,334,000,000 456,000,000 266,000,000 293,000,000 296,000,000 274,000,000 268,000,000 179,000,000 280,000,000 419,000,000 578,000,000 257,000,000 222,000,000 111,931,000 -106,000,000 169,000,000 159,000,000 264,449,000 -152,000,000 112,000,000 65,000,000 -66,735,000 65,000,000 108,000,000 191,000,000 488,815,000 -289,000,000 23,000,000 80,000,000 39,000,000 34,000,000 2,000,000 28,000,000 -28,000,000 76,000,000   -7,000,000 -16,000,000 -14,000,000 36,000,000 -43,000,000 -83,000,000 54,000,000 32,000,000 -20,000,000 67,000,000 -66,000,000 15,000,000 63,000,000 82,000,000 82,000,000 940,000,000 35,000,000 95,000,000 29,000,000 -1,000,000 -14,000,000 183,000,000 -33,000,000 104,000,000 -15,000,000 -31,000,000 -75,000,000 -59,000,000 -30,000,000 75,000,000 70,000,000 -408,000,000 -21,000,000 -3,000,000  
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                              
      depreciation and amortization
    		218,000,000 208,000,000 206,000,000 193,000,000 209,000,000 208,000,000 208,000,000 216,000,000 224,000,000 213,000,000 217,000,000 213,000,000 209,000,000 216,000,000 203,000,000 201,000,000 209,000,000 221,000,000 224,000,000 -583,714,000 215,000,000 206,000,000 203,000,000 -587,038,000 205,000,000 214,000,000 208,000,000 -570,171,000 204,000,000 194,000,000 204,000,000 -634,265,000 219,000,000 218,000,000 205,000,000 215,000,000 212,000,000 208,000,000 185,000,000 197,000,000 207,000,000 240,000,000 207,000,000 209,000,000 193,000,000 191,000,000 119,000,000 121,000,000 114,000,000 116,000,000 110,000,000 100,000,000 104,000,000 105,000,000 103,000,000 104,000,000 101,000,000 101,000,000 101,000,000 97,000,000 95,000,000 95,000,000 97,000,000 97,000,000 97,000,000 96,000,000 90,000,000 92,000,000 95,000,000 93,000,000 91,000,000 89,000,000 89,000,000 90,000,000 105,000,000 92,000,000 96,000,000 98,000,000 
      deferred income tax expense
    		40,000,000 7,000,000 4,000,000 -74,000,000 64,000,000 -55,000,000 -38,000,000 -23,000,000 38,000,000 29,000,000 8,000,000 1,000,000 76,000,000 69,000,000 63,000,000 67,000,000 135,000,000 24,000,000 24,000,000      15,000,000 23,000,000 19,000,000  2,000,000 38,000,000 70,000,000  -64,000,000 9,000,000 -5,000,000 6,000,000 31,000,000    12,000,000         34,000,000 21,000,000 -1,000,000 38,000,000 -21,000,000 11,000,000 56,000,000 35,000,000 32,000,000 -996,000,000 7,000,000 5,000,000 3,000,000 6,000,000 8,000,000 3,000,000 -24,000,000 -5,000,000 -5,000,000 21,000,000          
      stock-based compensation expense
    		38,000,000 20,000,000 21,000,000 15,000,000 16,000,000 19,000,000 17,000,000 18,000,000 15,000,000 19,000,000 14,000,000 9,000,000 13,000,000 18,000,000 16,000,000 13,000,000 13,000,000 16,000,000 14,000,000  11,000,000 14,000,000 13,000,000  11,000,000 12,000,000 11,000,000  14,000,000 11,000,000 9,000,000  15,000,000 17,000,000 16,000,000 19,000,000 16,000,000 19,000,000 17,000,000 18,000,000 15,000,000 10,000,000 15,000,000 14,000,000 12,000,000 10,000,000 7,000,000 8,000,000 11,000,000 8,000,000 7,000,000 9,000,000 8,000,000 7,000,000 5,000,000 5,000,000 7,000,000 4,000,000 5,000,000 6,000,000 7,000,000 5,000,000 5,000,000 6,000,000 7,000,000 6,000,000 7,000,000 10,000,000 10,000,000          
      impairment and restructuring charges, and acquisition-related costs
    		23,000,000 24,000,000 19,000,000 27,000,000 19,000,000 29,000,000 27,000,000 53,000,000 47,000,000 16,000,000 21,000,000 129,000,000 24,000,000 57,000,000 16,000,000 30,000,000 15,000,000 20,000,000 20,000,000  57,000,000 54,000,000 55,000,000  46,000,000 36,000,000 19,000,000  46,000,000 30,000,000 47,000,000  329,000,000 121,000,000 31,000,000 22,000,000 28,000,000 52,000,000 44,000,000 193,000,000 29,000,000 63,000,000 37,000,000 32,000,000 21,000,000 58,000,000 20,000,000 11,000,000 14,000,000                              
      litigation and investigation costs
    		-11,000,000 28,000,000 17,000,000 17,000,000 9,000,000 5,000,000 4,000,000 19,000,000 14,000,000 10,000,000 4,000,000 20,000,000 12,000,000 18,000,000 20,000,000 52,000,000 29,000,000 22,000,000 13,000,000  9,000,000 2,000,000 2,000,000  84,000,000 18,000,000 13,000,000  9,000,000 13,000,000 6,000,000  6,000,000 2,000,000 4,000,000 114,000,000 173,000,000 224,000,000 50,000,000 14,000,000 3,000,000 6,000,000 4,000,000 12,000,000 3,000,000 28,000,000 1,000,000 2,000,000 0 2,000,000 0 1,000,000 2,000,000 31,000,000 5,000,000 8,000,000 11,000,000  2,000,000 2,000,000 2,000,000   9,000,000 1,000,000  -5,000,000 3,000,000 47,000,000 12,000,000         
      net gains on sales, consolidation and deconsolidation of facilities
    		  -22,000,000 -10,000,000 -348,000,000 -58,000,000 -2,500,000,000 -11,000,000 1,000,000        -412,000,000            7,000,000                                                  
      income from early extinguishment of debt
    		   0 0 0 8,000,000 0 0   0 0 66,000,000 43,000,000 0 20,000,000 31,000,000 23,000,000  312,000,000    180,000,000 0 47,000,000  0 1,000,000 1,000,000  138,000,000         0 24,000,000 0 0 0 0 171,000,000 177,000,000                          0 0 15,000,000 0 
      equity in earnings of unconsolidated affiliates, net of distributions received
    		-5,000,000 -13,000,000 5,000,000 -20,000,000 -6,000,000 -6,000,000 3,000,000 -18,000,000 -2,000,000 -4,000,000 11,000,000 -12,000,000 -4,000,000 -3,000,000 21,000,000 -20,000,000 0 -18,000,000 28,000,000  28,000,000 -28,000,000 -11,000,000 6,150,000 -4,000,000 -5,000,000 3,000,000 -8,844,000 -1,000,000 1,000,000 9,000,000 4,645,000 -8,000,000 -15,000,000 -8,000,000 -2,000,000 12,000,000                                          
      amortization of debt discount and debt issuance costs
    		6,000,000 6,000,000 6,000,000 5,000,000 7,000,000 6,000,000 8,000,000 7,000,000 7,000,000 9,000,000 9,000,000 10,000,000 8,000,000 7,000,000 8,000,000 8,000,000 8,000,000 8,000,000 9,000,000  10,000,000 10,000,000 10,000,000  4,000,000 10,000,000 11,000,000  11,000,000 11,000,000 11,000,000  11,000,000 8,000,000 12,000,000 11,000,000 10,000,000 9,000,000 11,000,000 14,000,000 7,000,000 7,000,000 7,000,000 7,000,000 7,000,000 7,000,000 3,000,000 4,000,000 5,000,000 6,000,000 5,000,000 6,000,000 5,000,000 7,000,000 8,000,000 7,000,000 8,000,000                      
      net gains from the sale of investments and long-lived assets
    		   -2,000,000 -1,000,000   -4,000,000 -10,000,000 -1,000,000 -14,000,000 -2,000,000                                                                   
      other items
    		-2,000,000 -3,000,000 2,000,000 -1,000,000 0 2,000,000 -5,000,000 -3,000,000 2,000,000 -1,000,000 -2,000,000 1,000,000 71,000,000 5,000,000 -64,000,000 -10,000,000 -1,000,000 -15,000,000 -7,000,000  -1,000,000 -5,000,000 2,000,000  -4,000,000 -3,000,000 -7,000,000  -21,000,000 0 -1,000,000  6,000,000 13,000,000 1,000,000 0 2,000,000 85,000,000 -1,000,000   -24,000,000 -18,000,000 2,000,000 0 0 1,000,000 0 2,000,000 9,000,000 9,000,000 -3,000,000 5,000,000 18,000,000 -7,000,000 8,000,000 -13,000,000 -27,000,000 7,000,000 10,000,000 6,000,000 -4,000,000 -8,000,000 -3,000,000 9,000,000 9,000,000 5,000,000 -6,000,000 3,000,000 3,000,000 0   8,000,000 1,000,000 3,000,000 3,000,000 4,000,000 
      changes in cash from operating assets and liabilities:
    		                                                                              
      accounts receivable
    		28,000,000 109,000,000 -69,000,000 62,000,000 106,000,000 340,000,000 -263,000,000 -60,000,000 24,000,000 -28,000,000 35,000,000 -101,000,000 35,000,000 77,000,000 -151,000,000 5,000,000 -101,000,000 -48,000,000 -53,000,000  -37,000,000 303,000,000 14,000,000  -36,000,000 20,000,000 -158,000,000  -23,000,000 53,000,000 -66,000,000  -373,000,000 -448,000,000 -431,000,000 -272,000,000 -453,000,000 -508,000,000 -345,000,000 -295,000,000 -484,000,000 -587,000,000             -155,000,000 -192,000,000 -278,000,000 -207,000,000 -160,000,000 -135,000,000 -242,000,000 -148,000,000 -179,000,000 -90,000,000 -229,000,000 -170,000,000 -121,000,000 -117,000,000 -243,000,000          
      inventories and other current assets
    		-67,000,000 117,000,000 -108,000,000 -96,000,000 -6,000,000 34,000,000 -18,000,000 -90,000,000 -209,000,000 110,000,000 50,000,000 -153,000,000 -84,000,000 -8,000,000 181,000,000 59,000,000 -167,000,000 -74,000,000 130,000,000  -14,000,000 21,000,000 23,000,000  -34,000,000 51,000,000 -115,000,000  -71,000,000 185,000,000 -41,000,000  -63,000,000 12,000,000 -65,000,000 -12,000,000 -18,000,000 -68,000,000 -98,000,000 110,000,000 -74,000,000 -326,000,000 -66,000,000            22,000,000 55,000,000 -113,000,000 -19,000,000 10,000,000 -11,000,000 3,000,000 3,000,000 -9,000,000 0 -16,000,000 -6,000,000 -11,000,000 14,000,000 1,000,000   -3,000,000 10,000,000 11,000,000   16,000,000  
      income taxes
    		5,000,000 -122,000,000 132,000,000 -805,000,000 108,000,000 -70,000,000 783,000,000 56,000,000 -15,000,000 -107,000,000 76,000,000 33,000,000 27,000,000 -115,000,000 29,000,000 1,000,000 42,000,000 6,000,000 19,000,000  -5,000,000 12,000,000 2,000,000  -2,000,000 -11,000,000 9,000,000  4,000,000    -7,000,000   -45,000,000 28,000,000   1,000,000 8,000,000        3,000,000    3,000,000  -18,000,000 -12,000,000 -14,000,000 -37,000,000 -10,000,000 33,000,000 17,000,000 -91,000,000 -8,000,000 17,000,000 4,000,000 11,000,000 -3,000,000 -12,000,000 -17,000,000 9,000,000 14,000,000    -4,000,000    
      accounts payable, accrued expenses and other current liabilities
    		213,000,000 0 24,000,000 -153,000,000 247,000,000              -87,000,000  337,000,000 1,353,000,000 -144,000,000  180,000,000 -108,000,000 -109,000,000  177,000,000 -188,000,000 -183,000,000  204,000,000 -16,000,000 71,000,000 8,000,000 -114,000,000 29,000,000 306,000,000 -67,000,000 -200,000,000 385,000,000   29,000,000          20,000,000 -74,000,000 -44,000,000 62,000,000 18,000,000 -18,000,000 -146,000,000 49,000,000 82,000,000 -2,000,000 -117,000,000 15,000,000 45,000,000 72,000,000 -161,000,000          
      other long-term liabilities
    		18,000,000 40,000,000 -8,000,000 -27,000,000 -5,000,000 -1,000,000 24,000,000 4,000,000 -2,000,000 21,000,000 -9,000,000 13,000,000 13,000,000 -20,000,000 -21,000,000 20,000,000 14,000,000 -12,000,000 6,000,000  115,000,000 141,000,000 -51,000,000  -19,000,000 -33,000,000 37,000,000  -34,000,000 -49,000,000 1,000,000  -41,000,000 -8,000,000 14,000,000 10,000,000 24,000,000 7,000,000 -9,000,000 12,000,000 28,000,000 6,000,000 -9,000,000 34,000,000 13,000,000   -22,000,000 27,000,000 -17,000,000 -6,000,000 10,000,000 16,000,000  -19,000,000 -4,000,000 12,000,000 -35,000,000 -5,000,000 9,000,000 -27,000,000 -7,000,000 5,000,000 1,000,000 -12,000,000 -10,000,000 -1,000,000   16,000,000 8,000,000 6,000,000 9,000,000 14,000,000 17,000,000 -16,000,000 31,000,000 9,000,000 
      payments for restructuring charges, acquisition-related costs, and litigation costs and settlements
    		-3,000,000 -45,000,000 -36,000,000 -34,000,000 -55,000,000 -39,000,000 -25,000,000 -49,000,000 -27,000,000 -54,000,000 -24,000,000 -57,000,000 -59,000,000 -42,000,000 -56,000,000 -37,000,000 -31,000,000 -34,000,000 -51,000,000  -138,000,000 -46,000,000 -68,000,000  -56,000,000 -48,000,000 -32,000,000  -50,000,000 -30,000,000 -33,000,000  -26,000,000 -559,000,000 -33,000,000 -30,000,000 -69,000,000 -43,000,000 -71,000,000 -53,000,000 -33,000,000 -53,000,000                                     
      net cash from operating activities
    		1,058,000,000 936,000,000 815,000,000 -331,000,000 1,045,000,000 747,000,000 586,000,000 824,000,000 503,000,000 598,000,000 449,000,000 421,000,000 315,000,000 119,000,000 228,000,000 357,000,000 432,000,000 245,000,000 534,000,000 -2,503,798,000 593,000,000 2,239,000,000 129,000,000 -386,035,000 419,000,000 284,000,000 10,000,000 -468,532,000 338,000,000 348,000,000 113,000,000 -406,934,000 308,000,000 -293,000,000 269,000,000 435,000,000 147,000,000 191,000,000 482,000,000 410,000,000 -57,000,000 219,000,000 221,000,000   255,000,000 206,000,000   256,000,000 136,000,000   173,000,000 148,000,000 178,000,000 -2,000,000  128,000,000 191,000,000 -22,000,000 141,000,000 120,000,000 170,000,000 -6,000,000 67,000,000 151,000,000 123,000,000 -133,000,000 112,000,000 83,000,000    -15,000,000 184,000,000 516,000,000 123,000,000 
      capex
    		-280,000,000 -193,000,000 1,325,000,000 -330,000,000 -216,000,000 -145,000,000 -240,000,000 -208,000,000 -176,000,000 -132,000,000 -235,000,000 -290,000,000 -165,000,000 -152,000,000 -155,000,000 -304,000,000 -112,000,000 -225,000,000 1,715,000,000 0 -86,000,000 -106,000,000 -182,000,000 0 -134,000,000 -136,000,000 1,415,000,000 0 -136,000,000 -125,000,000 -143,000,000 0 -144,000,000 -261,000,000 -201,000,000 -205,000,000 -208,000,000 -276,000,000 -207,000,000 -175,000,000 -184,000,000 -199,000,000 0   0 0   0 0   0 -100,000,000 -82,000,000 -116,000,000  -119,000,000 -70,000,000 -78,000,000 -181,000,000 -78,000,000 -53,000,000 -86,000,000 0 -105,000,000 -83,000,000 -160,000,000 0 0    0 0 0 0 
      free cash flows
    		778,000,000 743,000,000 2,140,000,000 -661,000,000 829,000,000 602,000,000 346,000,000 616,000,000 327,000,000 466,000,000 214,000,000 131,000,000 150,000,000 -33,000,000 73,000,000 53,000,000 320,000,000 20,000,000 2,249,000,000 -2,503,798,000 507,000,000 2,133,000,000 -53,000,000 -386,035,000 285,000,000 148,000,000 1,425,000,000 -468,532,000 202,000,000 223,000,000 -30,000,000 -406,934,000 164,000,000 -554,000,000 68,000,000 230,000,000 -61,000,000 -85,000,000 275,000,000 235,000,000 -241,000,000 20,000,000 221,000,000   255,000,000 206,000,000   256,000,000 136,000,000   173,000,000 48,000,000 96,000,000 -118,000,000  9,000,000 121,000,000 -100,000,000 -40,000,000 42,000,000 117,000,000 -92,000,000 67,000,000 46,000,000 40,000,000 -293,000,000 112,000,000 83,000,000    -15,000,000 184,000,000 516,000,000 123,000,000 
      cash flows from investing activities:
    		                                                                              
      purchases of property and equipment
    		-280,000,000 -193,000,000 -173,000,000 -330,000,000 -216,000,000 -145,000,000 -240,000,000 -208,000,000 -176,000,000 -132,000,000 -235,000,000 -290,000,000 -165,000,000 -152,000,000 -155,000,000 -304,000,000 -111,000,000 -122,000,000 -121,000,000                                                            
      purchases of businesses or joint venture interests, net of cash acquired
    		-119,000,000 -120,000,000 -27,000,000 -47,000,000 -14,000,000 -61,000,000 -449,000,000 -114,000,000 -14,000,000 -48,000,000 -48,000,000 -10,000,000 -158,000,000 -26,000,000 -40,000,000 -1,156,000,000 0 -39,000,000 -25,000,000  -5,000,000 -1,000,000 -55,000,000  -10,000,000 -11,000,000 -2,000,000  -8,000,000 -73,000,000 -16,000,000  -15,000,000 -21,000,000 -2,000,000 -65,000,000 -29,000,000 -220,000,000 -84,000,000 -625,000,000 -11,000,000 -243,000,000                                     
      proceeds from sales of facilities and other assets
    		4,000,000 3,000,000 11,000,000 16,000,000 917,000,000 18,000,000 4,030,000,000 33,000,000 22,000,000 3,000,000 13,000,000 1,000,000 0 61,000,000 148,000,000  1,111,000,000 111,000,000 13,000,000          17,000,000 56,000,000 425,000,000  752,000,000 0 0 0 573,000,000 521,000,000                                        105,000,000 
      proceeds from sales of marketable securities and long-term investments
    		37,000,000 23,000,000 14,000,000 38,000,000 8,000,000 10,000,000 7,000,000                                                                        
      purchases of marketable securities and long-term investments
    		-31,000,000 -21,000,000 -17,000,000 -48,000,000 -20,000,000 -16,000,000 -10,000,000                                                                        
      net cash from investing activities
    		-385,000,000 -314,000,000 -187,000,000 -372,000,000 667,000,000 -194,000,000 3,328,000,000 -333,000,000 -169,000,000 -181,000,000 -286,000,000 -306,000,000 -302,000,000 -140,000,000 -60,000,000 -1,516,000,000 997,000,000 -50,000,000 -145,000,000 196,808,000 -117,000,000 -85,000,000 -204,000,000 392,582,000 -123,000,000 -164,000,000 -139,000,000 -182,230,000 -105,000,000 -148,000,000 373,000,000 -256,946,000 535,000,000 -280,000,000 -204,000,000 -266,000,000 320,000,000 -45,000,000 -287,000,000 -798,000,000 -187,000,000 -408,000,000             -93,000,000 -102,000,000 -129,000,000  -145,000,000 -58,000,000 -68,000,000 -180,000,000 -95,000,000 -24,000,000 174,000,000 -71,000,000 8,000,000 -50,000,000 -161,000,000          
      cash flows from financing activities:
    		                                                                              
      repayments of borrowings
    		-28,000,000 -30,000,000 -32,000,000 -31,000,000 -33,000,000 -38,000,000 -2,141,000,000 -64,000,000 -41,000,000 -1,392,000,000 -45,000,000  -42,000,000 -1,865,000,000 -879,000,000                                        -2,000,000 -1,000,000 -1,000,000 0 -874,000,000 -5,000,000 -7,000,000 -6,000,000 -384,000,000 -900,000,000 -1,000,000 0 0 0 -1,000,000          
      proceeds from borrowings
    		6,000,000 14,000,000 1,000,000 7,000,000 8,000,000 6,000,000 2,000,000 2,000,000 6,000,000 1,350,000,000 12,000,000  7,000,000 2,011,000,000 2,000,000                                       900,000,000 0 0 0 0 600,000,000 0 1,000,000 0 0                
      repurchases of common stock
    		-93,000,000 -747,000,000 -348,000,000 0 -124,000,000 -270,000,000 -278,000,000 -110,000,000 0 -40,000,000 -50,000,000                                 0 0          -124,000,000                        
      distributions paid to noncontrolling interests
    		-211,000,000 -185,000,000 -189,000,000 -185,000,000 -173,000,000 -161,000,000 -162,000,000 -169,000,000 -155,000,000 -136,000,000 -134,000,000 -128,000,000 -122,000,000 -175,000,000 -135,000,000 -107,000,000 -104,000,000 -93,000,000 -119,000,000  -84,000,000 -24,000,000 -76,000,000  -79,000,000 -70,000,000 -74,000,000  -77,000,000 -76,000,000 -64,000,000  -55,000,000 -67,000,000 -56,000,000 -51,000,000 -44,000,000 -45,000,000 -42,000,000 -12,000,000 -11,000,000 -15,000,000             -4,000,000 -2,000,000 -2,000,000 -2,000,000 -3,000,000 -2,000,000 -1,000,000 -2,000,000 -2,000,000                
      proceeds from the sale of noncontrolling interests
    		9,000,000 7,000,000 11,000,000 10,000,000 3,000,000 5,000,000 5,000,000 6,000,000 7,000,000 5,000,000 25,000,000  7,000,000                                                                  
      purchases of noncontrolling interests
    		-9,000,000 -38,000,000 -41,000,000 -73,000,000 -39,000,000 -36,000,000 -52,000,000 -40,000,000 -48,000,000 -38,000,000 -41,000,000 -39,000,000 -32,000,000 -15,000,000 -14,000,000 -8,000,000 -14,000,000 -3,000,000 -2,000,000 30,133,000    -4,792,000 -2,000,000 -3,000,000 -3,000,000 634,785,000 -1,000,000 -633,000,000 -9,000,000 716,553,000 -717,000,000                                              
      advances from managed care payers
    		   0 0                                                                          
      repayments of advances from managed care payers
    		-21,000,000 -1,000,000 -11,000,000 -150,000,000                                                                           
      taxes paid related to net share settlement, net of proceeds from shares issued under stock-based compensation plans
    		                                                                              
      net cash from financing activities
    		-323,000,000 -996,000,000 -648,000,000 -372,000,000 -498,000,000 -154,000,000 -2,661,000,000 -317,000,000 -214,000,000 -249,000,000 -255,000,000 -465,000,000 -156,000,000 -33,000,000 -1,127,000,000 1,231,000,000 -1,331,000,000 -142,000,000 -694,000,000 -701,819,000 -690,000,000 747,000,000 426,000,000 81,976,000 -231,000,000 -123,000,000 -30,000,000 758,698,000 -136,000,000 -771,000,000 -123,000,000 956,235,000 -889,000,000 640,000,000 -72,000,000 -241,000,000 -95,000,000 -240,000,000 -44,000,000 502,000,000 236,000,000 182,000,000 -89,000,000 284,000,000 338,000,000       -153,000,000 169,000,000  -134,000,000 -79,000,000 -7,000,000 -19,000,000 -296,000,000 -11,000,000 -11,000,000 -2,000,000 -52,000,000 -40,000,000 -23,000,000 -1,000,000 1,000,000     0 1,000,000 1,000,000 -2,000,000 1,000,000 349,000,000 1,000,000 
      net increase in cash and cash equivalents
    		350,000,000 -374,000,000 -20,000,000 -1,075,000,000 1,214,000,000 399,000,000 1,253,000,000 174,000,000 120,000,000       72,000,000 98,000,000 53,000,000 -305,000,000  -214,000,000 2,901,000,000 351,000,000    -159,000,000    363,000,000  -46,000,000 67,000,000 -7,000,000 -72,000,000 372,000,000 -94,000,000 151,000,000   -7,000,000 -206,000,000 265,000,000 28,000,000             7,000,000 -313,000,000 122,000,000 -101,000,000 -41,000,000 -27,000,000 106,000,000 145,000,000          -114,000,000 97,000,000 843,000,000 130,000,000 
      cash and cash equivalents at beginning of period
    		0 0 3,019,000,000 0 0 0 1,228,000,000 0 0 0 858,000,000 0 0 0 2,364,000,000 0 0 0 2,446,000,000  0 0 262,000,000  0 0 411,000,000  0 0 611,000,000  0 0 0 0 356,000,000 0 0 0 193,000,000 0 0 0 113,000,000 0 0 0 364,000,000 0 0 0 113,000,000 0 0 0 405,000,000 0 0 0 690,000,000 0 0 0 507,000,000 0 0 0 572,000,000 0 0 0 784,000,000 1,373,000,000 0 0 654,000,000 0 
      cash and cash equivalents at end of period
    		350,000,000 -374,000,000 2,999,000,000 -1,075,000,000 1,214,000,000 399,000,000 2,481,000,000 174,000,000 120,000,000 168,000,000 766,000,000 -350,000,000 -143,000,000 -54,000,000 1,405,000,000 72,000,000 98,000,000 53,000,000 2,141,000,000  -214,000,000 2,901,000,000 613,000,000  65,000,000 -3,000,000 252,000,000  97,000,000 -571,000,000 974,000,000  -46,000,000 67,000,000 -7,000,000 -72,000,000 728,000,000 -94,000,000 151,000,000 114,000,000 185,000,000 -7,000,000 -206,000,000 265,000,000 141,000,000 31,000,000 -8,000,000 -5,000,000 95,000,000 281,000,000 1,000,000 -22,000,000 104,000,000 -72,000,000 -79,000,000 -3,000,000 267,000,000 7,000,000 -313,000,000 122,000,000 589,000,000 -41,000,000 -27,000,000 106,000,000 652,000,000 -5,000,000 160,000,000 74,000,000 278,000,000 -83,000,000 -20,000,000 91,000,000 584,000,000 975,000,000 -114,000,000 97,000,000 1,497,000,000 130,000,000 
      supplemental disclosures:
    		                                                                              
      interest paid, net of capitalized interest
    		-100,000,000 -300,000,000 -99,000,000 -296,000,000 -96,000,000 -297,000,000 -162,000,000 -293,000,000 -144,000,000 -268,000,000 -177,000,000 -247,000,000 -185,000,000 -250,000,000 -166,000,000 -273,000,000 -178,000,000 -296,000,000 -190,000,000  -292,000,000 -293,000,000 -172,000,000  -221,000,000 -326,000,000 -158,000,000  -151,000,000 -332,000,000 -169,000,000  -149,000,000 -336,000,000 -129,000,000 -335,000,000 -132,000,000 -340,000,000 -134,000,000 -268,000,000 -117,000,000 -239,000,000 -127,000,000 -255,000,000 -105,000,000 -131,000,000 -69,000,000 -101,000,000 -125,000,000 -88,000,000 -107,000,000 -79,000,000 -102,000,000 -92,000,000 -73,000,000 -85,000,000 -97,000,000 -89,000,000 -112,000,000 -89,000,000 -112,000,000 -99,000,000 -100,000,000 -91,000,000 -149,000,000 -70,000,000 -126,000,000 -70,000,000 -125,000,000 -81,000,000 -123,000,000 -67,000,000 -124,000,000 -123,000,000 -131,000,000 -67,000,000 -94,000,000  
      income tax payments
    		-87,000,000 -235,000,000 -7,000,000 -963,000,000 -68,000,000 -235,000,000 -5,000,000 -31,000,000 -54,000,000   -13,000,000 -8,000,000 -132,000,000 -8,000,000 -38,000,000 -20,000,000 -32,000,000 -2,000,000  -5,000,000    -5,000,000    -3,000,000    -10,000,000 0 -4,000,000           -1,000,000 3,000,000      -2,000,000                          
      hospital operations:
    		                                                                              
      goodwill at beginning of period, net of accumulated impairment losses
    		0    0                                                                          
      goodwill acquired during the year, net of purchase price allocation adjustments
    		                                                                              
      goodwill related to assets held for sale and disposed
    		    -183,000,000                                                                          
      goodwill at end of period, net of accumulated impairment losses
    		0    -172,000,000                                                                          
      ambulatory care:
    		                                                                              
      goodwill at beginning of period
    		0                                                                              
      goodwill related to assets held for sale and disposed or deconsolidated facilities
    		                                                                              
      goodwill at end of period
    		223,000,000                                                                              
      total goodwill, net of accumulated impairment losses
    		223,000,000                                                                              
      net incomees (gains) on sales, consolidation and deconsolidation of facilities
    		          -13,000,000          -1,000,000 -1,000,000 -2,000,000  1,000,000 1,000,000 1,000,000                                                    
      at march 31, 2025:
    		                                                                              
      other intangible assets with finite useful lives:
    		                                                                              
      capitalized software costs
    		  1,498,000,000              -1,000,000 -103,000,000 1,836,000,000      22,000,000 8,000,000 1,607,000,000                                                    
      contracts
    		  241,000,000              -1,000,000 -1,000,000 872,000,000      1,000,000 4,000,000 870,000,000                                                    
      other
    		  91,000,000              1,000,000 -10,000,000 111,000,000      -1,000,000 -1,000,000 106,000,000                                                    
      other intangible assets with finite lives
    		  1,830,000,000                                                                            
      other intangible assets with indefinite useful lives:
    		                                                                              
      trade names
    		  105,000,000              0 0 102,000,000      0 0 102,000,000                                                    
      other intangible assets with indefinite lives
    		  882,000,000                                                                            
      total other intangible assets
    		  2,712,000,000                                                                            
      debt issuance costs
    		       0 -1,000,000   0 0 -21,000,000 -3,000,000 -16,000,000 0    -26,000,000 -21,000,000 -1,000,000  -45,000,000 0 -18,000,000      -33,000,000     -4,000,000 -4,000,000                                        
      current assets
    		                                                                              
      noncurrent assets
    		                                                                              
      current liabilities
    		                                                                              
      noncurrent liabilities
    		                                                                              
      noncontrolling interests
    		                                                                              
      net operating revenues
    		                                                                              
      net income attributable to the investees
    		                                                                              
      purchase price allocation adjustments
    		                                                                              
      accounts payable, accrued expenses, contract liabilities and other current liabilities
    		      19,000,000 253,000,000 130,000,000 62,000,000 -230,000,000 44,000,000 -178,000,000 -404,000,000 -360,000,000 -435,000,000 83,000,000                                                              
      pre-tax loss (income) from discontinued operations
    		                     0 1,000,000        -1,000,000     2,000,000 5,000,000                                          
      net cash from operating activities from discontinued operations, excluding income taxes
    		           0             1,000,000 -3,000,000 -2,000,000  -1,000,000 -2,000,000 -1,000,000  -1,000,000     -3,000,000    -7,000,000             -22,000,000 -6,000,000 -13,000,000 2,000,000 -7,000,000 3,000,000 2,000,000 9,000,000 3,000,000 -28,000,000 56,000,000  34,000,000    -6,000,000 -8,000,000 17,000,000  -24,000,000 32,000,000 45,000,000 -42,000,000 
      purchases of marketable securities and equity investments
    		       -50,000,000 -17,000,000 -19,000,000 -18,000,000 -24,000,000 -27,000,000 -22,000,000 -19,000,000 -85,000,000 -4,000,000 -8,000,000 -11,000,000  -31,000,000 -6,000,000 -4,000,000                                                        
      medicare advances and grants received by unconsolidated affiliates, net of recoupment
    		               -59,000,000 -14,000,000                                                              
      grant funds received from covid-19 relief programs:
    		                                                                              
      included in cash flows from operating activities:
    		                                                                              
      hospital operations
    		        -4,000,000 4,000,000 3,000,000  -46,000,000 93,000,000 4,000,000                                                                
      ambulatory care
    		             1,000,000 1,000,000                                                                
      included in cash flows from financing activities:
    		                                                                              
      cash‑managed affiliates
    		                                                                              
      pre-tax income from discontinued operations
    		              -1,000,000          -1,000,000 -2,000,000 -10,000,000               0   8,000,000      -3,000,000    2,000,000    3,000,000                22,000,000 18,000,000 23,000,000 148,000,000 
      proceeds from sales of marketable securities, long-term investments and other assets
    		        14,000,000 17,000,000 9,000,000 15,000,000 52,000,000 3,000,000 6,000,000 13,000,000 0 12,000,000 6,000,000  9,000,000 25,000,000 10,000,000  43,000,000 5,000,000 4,000,000  22,000,000 9,000,000 134,000,000  4,000,000 26,000,000 12,000,000 12,000,000 12,000,000 42,000,000 9,000,000 3,000,000 6,000,000 29,000,000 -1,000,000 0 3,000,000 9,000,000 3,000,000 0 3,000,000 8,000,000 4,000,000 2,000,000 3,000,000 28,000,000 21,000,000 5,000,000 5,000,000 53,000,000 15,000,000 4,000,000 12,000,000 12,000,000 6,000,000 31,000,000 18,000,000 32,000,000 178,000,000 4,000,000 10,000,000  205,000,000        
      grant income recognized from covid-19 relief programs:
    		                                                                              
      included in grant income:
    		                                                                              
      net decrease in cash and cash equivalents
    		          -92,000,000  -143,000,000 -54,000,000 -959,000,000          65,000,000    97,000,000                            -138,000,000         -5,000,000 160,000,000 74,000,000 -294,000,000          
      repayments of borrowings under credit facility
    		                    0 -500,000,000 -240,000,000  -785,000,000 -600,000,000 -495,000,000  -145,000,000    -750,000,000 -700,000,000 0 -200,000,000 -995,000,000 -935,000,000 -565,000,000 -625,000,000 -690,000,000 -465,000,000                                     
      proceeds from borrowings under credit facility
    		                    0 0 740,000,000  870,000,000 600,000,000 685,000,000  145,000,000    750,000,000 700,000,000 0 200,000,000 995,000,000 825,000,000 575,000,000 375,000,000 820,000,000 685,000,000 665,000,000 465,000,000 430,000,000     140,000,000 460,000,000                            
      repayments of other borrowings
    		               -38,000,000 -1,171,000,000 -1,471,000,000 -541,000,000  -3,015,000,000 -181,000,000 -48,000,000  -4,416,000,000 -48,000,000 -1,620,000,000  -77,000,000 -70,000,000 -91,000,000  -3,070,000,000 -42,000,000 -36,000,000 -38,000,000 -38,000,000 -38,000,000 -19,000,000 -1,960,000,000 -32,000,000 -28,000,000                                     
      proceeds from other borrowings
    		               1,459,000,000 4,000,000 1,405,000,000 4,000,000  2,503,000,000 1,305,000,000 7,000,000  4,202,000,000 9,000,000 1,507,000,000  1,000,000 7,000,000 7,000,000  2,951,000,000 756,000,000   1,000,000 -50,000,000 21,000,000 2,786,000,000 401,000,000 0 500,000,000 508,000,000 600,000,000 4,600,000,000 0 1,057,000,000 850,000,000 800,000,000 0                            
      proceeds from sale of noncontrolling interests
    		              4,000,000 11,000,000 2,000,000 6,000,000 6,000,000  2,000,000 3,000,000 2,000,000           3,000,000 4,000,000                                            
      net incomees on sales, consolidation and deconsolidation of facilities
    		              1,000,000                                                                
      grant payments received from covid-19 relief programs:
    		                                                                              
      unconsolidated affiliates for which we provide cash management services
    		                                                                              
      proceeds from sales of facilities and other assets — continuing operations
    		                    1,000,000 1,000,000 11,000,000  4,000,000 -1,000,000 41,000,000                                                    
      proceeds from sales of facilities and other assets — discontinued operations
    		                        0 0 17,000,000               2,000,000    5,000,000 10,000,000   0 35,000,000   0 0    1,000,000   0 0 -30,000,000 251,000,000  77,000,000 60,000,000 23,000,000 8,000,000         
      proceeds from shares issued under stock-based compensation plans, net of taxes paid relatedto net share settlement
    		                                                                              
      at september 30, 2021:
    		                                                                              
      total
    		                -1,000,000 -114,000,000 2,921,000,000      22,000,000 11,000,000 2,685,000,000                                                    
      proceeds from exercise of stock options and employee stock purchase plan
    		                 2,000,000 7,000,000  8,000,000 3,000,000 2,000,000  1,000,000 2,000,000 1,000,000  1,000,000 5,000,000 9,000,000                                                
      at june 30, 2021:
    		                                                                              
      other long-term assets
    		                  -8,000,000    -2,000,000  5,000,000 -2,000,000 -2,000,000  2,000,000 -4,000,000 7,000,000  -4,000,000    -10,000,000    2,000,000     -3,000,000 5,000,000 -23,000,000 29,000,000                              
      medicare advances and grants received by unconsolidated affiliates
    		                  19,000,000                                                            
      at march 31, 2021:
    		                                                                              
      cash flows from operating activities:
    		                                                                              
      benefit from doubtful accounts
    		                               -1,086,497,000 355,000,000 354,000,000 367,000,000 352,000,000 376,000,000 391,000,000 371,000,000 352,000,000 363,000,000 356,000,000 249,000,000 320,000,000 380,000,000 348,000,000 210,000,000 207,000,000 207,000,000 200,000,000 206,000,000 186,000,000 193,000,000 184,000,000 193,000,000 171,000,000 182,000,000 191,000,000 187,000,000 173,000,000 189,000,000 181,000,000 193,000,000 167,000,000 156,000,000 166,000,000 164,000,000 153,000,000 149,000,000 134,000,000 141,000,000 151,000,000 141,000,000 138,000,000 206,000,000 153,000,000 158,000,000 228,000,000 
      amortization of debt issue costs
    		                                                                              
      equity in earnings (losses) of unconsolidated affiliates, net of distributions received
    		                                                                              
      loss/(gain) on sale of assets
    		                                                                              
      noncash lease expense
    		                                                                              
      changes in operating assets and liabilities, net of effects from purchases of new businesses:
    		                                                                              
      decrease/(increase) in patient receivables
    		                                                                              
      decrease/(increase) in supplies, prepaid, and other assets
    		                                                                              
      increase in contract liabilities
    		                                                                              
      (decrease)/increase in accounts payable, accrued expenses, and other liabilities
    		                                                                              
      purchases of new businesses and equity interests, net of cash received
    		                                                                              
      sale of property and equipment
    		                                                                              
      decrease/(increase) in deposits and notes receivables
    		                                                                              
      other investing activities
    		                                                                              
      (increase)/decrease in funds due from united surgical partners, inc.
    		                                                                              
      proceeds from debt obligations
    		                                                                              
      payments on debt obligations
    		                                                                              
      distributions to noncontrolling interest owners
    		                                                                              
      sales of noncontrolling interests
    		                                                                              
      contribution from members
    		                                                                              
      distributions to members
    		                                                                              
      increase/(decrease) in cash and restricted cash
    		                                                                              
      cash and restricted cash, beginning of period
    		                                                                              
      cash and restricted cash, end of period
    		                                                                              
      supplemental information:
    		                                                                              
      cash paid for interest
    		                                                                              
      cash paid for income taxes
    		                                                                              
      noncash transactions:
    		                                                                              
      assets acquired under finance lease obligations
    		                                                                              
      (decrease)/increase in accounts payable due to property and equipment received but not paid
    		                                                                              
      tyler acquisition
    		                                                                              
      right of use assets acquired under operating leases
    		                                                                              
      reconciliation of cash and restricted cash:
    		                                                                              
      cash at beginning of period
    		                                                                              
      restricted cash at beginning of period
    		                                                                              
      cash and restricted cash at beginning of period
    		                                                                              
      cash at end of period
    		                                                                              
      restricted cash at end of period
    		                                                                              
      cash and restricted cash at end of period
    		                                                                              
      deferred income tax (benefit) expense
    		                    -197,000,000 30,000,000 -79,000,000                                                        
      purchases of property and equipment — continuing operations
    		                    -86,000,000 -106,000,000 -182,000,000  -156,000,000 -144,000,000 -192,000,000  -136,000,000 -125,000,000 -143,000,000  -144,000,000 -261,000,000 -201,000,000 -205,000,000 -208,000,000 -276,000,000 -207,000,000 -175,000,000 -184,000,000 -199,000,000             -100,000,000 -82,000,000 -116,000,000  -106,000,000 -70,000,000 -78,000,000 -181,000,000 -78,000,000 -53,000,000 -85,000,000  -99,000,000 -74,000,000 -159,000,000          
      at december 31, 2019:
    		                                                                              
      deferred income taxes
    		                    0 -90,000,000 259,000,000                                                        
      professional and general liability reserves
    		                    0 -37,000,000 622,000,000                                                        
      accumulated deficit
    		                    0 -48,000,000 -2,419,000,000                                                        
      income tax (payments) refunds
    		                      -3,000,000                           -4,000,000 2,000,000      -24,000,000         -1,000,000 0 -4,000,000 1,000,000 -6,000,000 0        
      at march 31, 2020:
    		                                                                              
      increase in patient receivables
    		                                                                              
      (increase)/decrease in supplies, prepaid, and other assets
    		                                                                              
      increase in accounts payable, accrued expenses, and other liabilities
    		                                                                              
      purchases of new businesses and equity interests, net of cash received of 0, 925, and 0 for 2019, 2018 and 2017, respectively
    		                                                                              
      change in deposits and notes receivables
    		                                                                              
      change in funds due from united surgical partners, inc.
    		                                                                              
      (decrease)/increase in cash and restricted cash
    		                                                                              
      assets acquired under capital leases
    		                                                                              
      centennial acquisition
    		                                                                              
      managed care
    		                                                                              
      medicare
    		                                                                              
      medicaid
    		                                                                              
      indemnity, self-pay, and other
    		                                                                              
      purchases of equity investments
    		                        -5,000,000 -8,000,000 -1,000,000  -6,000,000 -7,000,000 -30,000,000  -62,000,000 -2,000,000 -2,000,000 -17,000,000 -18,000,000 -116,000,000                                         
      proceeds from sales of noncontrolling interests
    		                        6,000,000 5,000,000 4,000,000  7,000,000 2,000,000 5,000,000  15,000,000                                              
      at september 30, 2019:
    		                                                                              
      at june 30, 2019:
    		                                                                              
      income tax refunds
    		                          9,000,000                            -11,000,000    0 17,000,000 17,000,000                  
      at march 31, 2019:
    		                                                                              
      loss on fixed asset impairment
    		                                                                              
      (gain) loss on sale of assets
    		                                                                              
      increase in supplies, prepaids, and other assets
    		                                                                              
      (decrease) /increase in accounts payable, accrued expenses, and other liabilities
    		                                                                              
      purchases of new businesses and equity interests, net of cash received of 925, 0 and 394 for 2018, 2017 and 2016, respectively
    		                                                                              
      increase in cash
    		                                                                              
      cash, beginning of period
    		                                                                              
      cash, end of period
    		                                                                              
      increase in accounts payable due to property and equipment received but not paid
    		                                                                              
      sunnyvale acquisition
    		                                                                              
      restricted cash borrowed
    		                                                                              
      restricted cash from purchases of equipment
    		                                                                              
      restricted cash from payments on debt obligations
    		                                                                              
      commercial and managed care providers
    		                                                                              
      government-related programs
    		                                                                              
      self-pay patients
    		                                                                              
      at september 30, 2018:
    		                                                                              
      gains on sales, consolidation and deconsolidation of facilities
    		                              -110,000,000  -104,000,000 0 -3,000,000 -1,000,000 -147,000,000                                          
      income tax refunds (payments)
    		                              1,000,000          1,000,000    -1,000,000    3,000,000              -7,000,000                
      gain on sale of assets
    		                                                                              
      purchases of new businesses and equity interests, net of cash received of 0 and 135 for 2017 and 2016, respectively
    		                                                                              
      proceeds from employee stock plan purchases
    		                                2,000,000                                              
      other assets
    		                                                                              
      pre-tax (income) income from discontinued operations
    		                                                3,000,000        15,000,000    -6,000,000                  
      purchase of noncontrolling interests
    		                                 -6,000,000 -3,000,000   0 0                                        
      proceeds from exercise of stock options
    		                                 0 1,000,000   0 6,000,000 2,000,000 7,000,000 3,000,000 12,000,000 5,000,000 6,000,000 0 1,000,000 6,000,000 15,000,000                          2,000,000 1,000,000 8,000,000  
      contributions from noncontrolling interests
    		                                     1,000,000 0 1,000,000 2,000,000 3,000,000 2,000,000 0 13,000,000 1,000,000 0             0 1,000,000                  
      undistributed earnings from affiliates
    		                                                                              
      deferred income tax benefit
    		                                      17,000,000                                        
      deferred debt issuance costs
    		                                         -1,000,000                -12,000,000 -15,000,000   1,000,000 -1,000,000 -24,000,000 -22,000,000              
      purchase of noncontrolling interest
    		                                        -254,000,000                                      
      purchases of property and equipment — discontinued operations
    		                                             0 0            -13,000,000   0 0 0 -1,000,000  -6,000,000 -9,000,000 -1,000,000          
      repurchases of preferred stock
    		                                             0                                 
      cash dividends on preferred stock
    		                                             0 0 0 0      -6,000,000 -6,000,000 -6,000,000 -6,000,000 -6,000,000 -6,000,000 -6,000,000                  
      pre-tax gain from discontinued operations
    		                                                                              
      proceeds from interest rate swap agreement
    		                                                         0    21,000,000                 
      purchases of businesses or joint venture interests
    		                                                      -14,000,000 -24,000,000 -18,000,000                      
      proceeds from borrowing under credit facility
    		                                              558,000,000 433,000,000 220,000,000    658,000,000                          
      impairment of long-lived assets and goodwill, and restructuring charges
    		                                                 7,000,000 6,000,000 3,000,000 3,000,000 9,000,000 8,000,000 2,000,000 8,000,000  3,000,000    7,000,000 1,000,000 5,000,000  1,000,000 2,000,000 1,000,000    3,000,000    9,000,000  
      fair market value adjustments related to interest rate swap and libor cap agreements
    		                                                   0 0 0 -17,000,000 -2,000,000 19,000,000 0 0   0 -4,000,000                
      payments against reserves for restructuring charges and litigation costs and settlements
    		                                                                 -21,000,000 -23,000,000            
      construction of new and replacement hospitals
    		                                                     0 0 0 0 0 -1,000,000 -7,000,000 -5,000,000 -11,000,000 -13,000,000 -18,000,000 -16,000,000 -10,000,000 -9,000,000 -27,000,000 -29,000,000          
      release of escrow funds
    		                                                                              
      net gain on sales of investments
    		                                                         0 0   0 0                
      gain from early extinguishment of debt
    		                                                               21,000,000 -134,000,000              
      purchases of marketable securities
    		                                                         0 0   0 -11,000,000   -9,000,000 -9,000,000 -1,000,000 -7,000,000          
      distributions received from investments in reserve yield plus fund
    		                                                          0     0 8,000,000              
      proceeds from hospital authority bonds
    		                                                         0 0   0 0   0    0         
      proceeds from issuance of mandatory convertible preferred stock
    		                                                         0    0                 
      payments against reserves for restructuring charges and litigation costs
    		                                                      -6,000,000 -14,000,000 -7,000,000  -25,000,000 -27,000,000 -24,000,000  -109,000,000 -28,000,000 -28,000,000    -27,000,000          
      purchase of property and equipment — discontinued operations
    		                                                                              
      impairment of long-lived assets and goodwill, and restructuring charges, net of insurance recoveries
    		                                                                     36,000,000 11,000,000        
      litigation and investigation costs, net of insurance recoveries
    		                                                             18,000,000                 
      (gain) income from early extinguishment of debt
    		                                                         2,000,000                     
      amortization of debt discount and issue costs
    		                                                                              
      pre-tax (gain) income from discontinued operations
    		                                                                              
      net cash from operating activities cash flows from investing activities:
    		                                                                              
      purchases of property and equipment—continuing operations
    		                                                                              
      purchases of property and equipment—discontinued operations
    		                                                                              
      purchases of business or joint venture interest
    		                                                                              
      proceeds from sales of facilities and other assets—discontinued operations
    		                                                                              
      distributions received from (reclassification of) investments in reserve yield plus fund
    		                                                             1,000,000                 
      proceeds from cash surrender value or basis reduction of insurance policies
    		                                                                 7,000,000             
      net cash from investing activities cash flows from financing activities:
    		                                                                              
      purchase of businesses or joint venture interest
    		                                                                              
      purchase of business or joint venture interest
    		                                                                 0             
      fair market value adjustments related to libor cap agreement
    		                                                            2,000,000                  
      net gain from early extinguishment of debt
    		                                                             0                 
      pretax income from discontinued operations
    		                                                             -9,000,000 3,000,000 20,000,000 9,000,000  10,000,000 -16,000,000 19,000,000          
      insurance recoveries for property damage
    		                                                                              
      purchase of business
    		                                                                              
      dividends paid to noncontrolling interests
    		                                                                -2,000,000              
      net gains on sales of investments
    		                                                                              
      pretax (income) income from discontinued operations
    		                                                                     -8,000,000 38,000,000 -1,000,000 31,000,000      
      cumulative effect of change in accounting principle
    		                                                                              
      insurance recoveries for business interruption and other costs
    		                                                                              
      net cash from operating activities from discontinued operations, excluding income taxes and insurance recoveries for business interruption and other costs
    		                                                                              
      reclassification of investments in reserve yield plus fund out of cash equivalents
    		                                                                 34,000,000             
      release of restricted cash related to letter of credit facility
    		                                                                              
      cumulative effect of changes in accounting principle
    		                                                                              
      proceeds from sale of marketable securities, long-term investments and other assets
    		                                                                              
      sale of new senior notes
    		                                                                          0 0 773,000,000 0 
      repurchases of senior notes
    		                                                                              
      stock-based compensation charges
    		                                                                      10,000,000 10,000,000 11,000,000 11,000,000 12,000,000 13,000,000 13,000,000 25,000,000 
      increases (decreases) in cash from changes in operating assets and liabilities:
    		                                                                              
      construction of new hospitals.
    		                                                                              
      proceeds from cash surrender value of insurance policies
    		                                                                              
      proceeds from sales of facilities — discontinued operations
    		                                                                       9,000,000 38,000,000      
      costs of litigation and investigations
    		                                                                              
      proceeds from sales of long-term investments and other assets
    		                                                                        174,000,000      
      income tax payments made
    		                                                                        -2,000,000      
      increases (decreases) in cash from changes in operating assets and liabilities, net of effects from sales of facilities:
    		                                                                              
      purchase of property and buyout of discontinued operation joint venture interest
    		                                                                              
      proceeds from sales of facilities, investments and other assets
    		                                                                         26,000,000     
      payments of borrowings
    		                                                                              
      income tax refunds received (payments made)
    		                                                                         -3,000,000 -6,000,000 -2,000,000 537,000,000  
      impairment of long-lived assets and restructuring charges
    		                                                                         1,000,000     
      increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of new businesses and sales of facilities:
    		                                                                              
      income taxes payable
    		                                                                         4,000,000   541,000,000  
      purchases of property and equipment:
    		                                                                              
      continuing operations
    		                                                                              
      gulf coast operations
    		                                                                              
      discontinued operations
    		                                                                              
      insurance recoveries
    		                                                                         10,000,000     
      impairment and restructuring charges
    		                                                                          205,000,000    
      construction of new hospitals
    		                                                                              
      deposits on purchases of property and equipment
    		                                                                              
      net cash released from escrow accounts to fund construction costs
    		                                                                              
      proceeds from sales of facilities, long-term investments and other assets
    		                                                                          36,000,000 46,000,000 71,000,000  
      investment in hospital authority bonds
    		                                                                              
      other items, including expenditures related to prior-year purchases of new businesses
    		                                                                            3,000,000  
      impairment of long-lived assets, goodwill and investment securities, and restructuring charges
    		                                                                              
      increase in cash from changes in operating assets and liabilities, net of effects from purchases and sales of businesses:
    		                                                                              
      cash released from escrow accounts to fund construction costs
    		                                                                              
      payments of other borrowings
    		                                                                              
      interest paid
    		                                                                             46,000,000 
      income taxes paid, net of refunds received
    		                                                                             0 
      cash released from escrow account to fund construction costs
    		                                                                              
      adjustments to reconcile net income
    		                                                                              
      income tax benefit related to stock option exercises
    		                                                                              
      discontinued operations impairment charge
    		                                                                              
      other items, including, in 2003, settlements of litigation and investigations
    		                                                                              
      repurchases of senior, senior subordinated and exchangeable subordinated notes
    		                                                                              
      impairment, restructuring and other unusual charges
    		                                                                              
      increases (decreases) in cash from changes in operating assets and liabilities, net of effects from purchases of businesses:
    		                                                                              
      net expenditures for discontinued operations and other unusual charges
    		                                                                              
      purchases of businesses, net of cash acquired
    		                                                                              
      purchases of treasury stock
    		                                                                              
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.